Elantan® (coronary heart disease)

Other available trademarks: Isangina™, Monoket™, Effox™, Elan™, Monocedocard™, Mononit™, Uniket™

Elantan® (isosorbide mononitrate) is indicated in:

• Long-term treatment of coronary artery disease
• Long-term treatment and prevention of angina pectoris (including post myocardial infarction)
• Long-term treatment of chronic congestive heart failure in combination with cardiac glycosides, diuretics, ACE-inhibitors or arterial vasodilators
• Pulmonary hypertension.

Elantan® may be prescribed for use in adults and elderly.